Novo Nordisk A/S (NVO)
38.58
+0.62
(+1.63%)
USD |
NYSE |
Mar 16, 16:00
38.48
-0.10
(-0.26%)
Pre-Market: 20:00
Novo Nordisk Price : 38.58 for March 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 231.02 |
| Evaxion AS | 3.82 |
| Regeneron Pharmaceuticals, Inc. | 756.91 |
| Viking Therapeutics, Inc. | 36.01 |
| DBV Technologies SA | 20.36 |
Price Related Metrics
| PE Ratio | 11.12 |
| PS Ratio | 3.674 |
| PEG Ratio | 1.970 |
| Price to Book Value | 7.411 |
| Price to Free Cash Flow | 39.02 |
| Earnings Yield | 8.99% |
| Market Cap | 171.43B |
| PEGY Ratio | 1.099 |
| Operating PE Ratio | 8.923 |
| Normalized PE Ratio | 11.12 |